Clinical trial · Observational
Study of Chemotherapy Side Effects in Cancer Patients: Non-invasive Optical Measurements of the Brain
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): no participant enrolled
Summary
Brief summary (as posted)
Currently there is no methodology that can assign a risk of development of chemo brain and thus, studies to understand how and why only some patients develop chemo brain along with studies of potential treatments face major hurdles. This study will define hemodynamic/optical parameters in normal individuals and cancer patients undergoing chemotherapy potentially identifying optical parameters that are associated with the development of chemo brain, leading to new insights into the origin of the chemo brain condition, and importantly potentially identifying parameters that may predict who will develop "chemo brain" in order to directing investigations of therapies.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Signs and Symptoms | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Diffuse optical spectroscopy and Near infrared spectroscopy | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Diagnostic tool
- description
- Diffuse optical spectroscopy and Near infrared spectroscopy are non-invasive methods measure tissue hemodynamics in real time, direct quantitative information and insights treatment-associated toxicity.
- interventionNames
- Device: Diffuse optical spectroscopy and Near infrared spectroscopy
Primary outcomes (1)
- measure
- Measurement of brain tissues blood flow
- timeFrame
- 6 months
- description
- Diffuse optical spectroscopy and Near infrared spectroscopy are non-invasive methods measure tissue hemodynamics in real time, direct quantitative information and insights treatment-associated toxicity.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * have a histologically proven cancer. * Planned initiation of chemotherapy * age range between 18-70 years Exclusion Criteria: * have NO a histologically proven cancer. * NO planned chemotherapy * age less than 18 years
References
Publications (0)
Data not yet available